167 related articles for article (PubMed ID: 32831023)
41. Differential expression of platelet activation markers in aspirin-sensitive asthmatics and normal subjects.
Taylor ML; Misso NL; Stewart GA; Thompson PJ
Clin Exp Allergy; 1996 Feb; 26(2):202-15. PubMed ID: 8835129
[TBL] [Abstract][Full Text] [Related]
42. Can mean platelet component be used as an index of platelet activity in stable coronary artery disease?
Cooke J; Murphy T; McFadden E; O'Reilly M; Cahill MR
Hematology; 2009 Apr; 14(2):111-4. PubMed ID: 19298724
[TBL] [Abstract][Full Text] [Related]
43. Serial changes in circulating M30 antigen, a biomarker of apoptosis, in patients with acute coronary syndromes: relationship with the severity of coronary artery disease.
Senturk T; Aydinlar A; Yilmaz Y; Oral AY; Ozdabakoglu O; Ulukaya E
Coron Artery Dis; 2009 Dec; 20(8):494-8. PubMed ID: 19770641
[TBL] [Abstract][Full Text] [Related]
44. Serum levels of apelin and ghrelin in patients with acute coronary syndromes and established coronary artery disease--KOZANI STUDY.
Kadoglou NP; Lampropoulos S; Kapelouzou A; Gkontopoulos A; Theofilogiannakos EK; Fotiadis G; Kottas G
Transl Res; 2010 May; 155(5):238-46. PubMed ID: 20403579
[TBL] [Abstract][Full Text] [Related]
45. Increased platelet surface expression of P-selectin and thrombospondin as markers of platelet activation in essential thrombocythaemia.
Griesshammer M; Beneke H; Nussbaumer B; Grünewald M; Bangerter M; Bergmann L
Thromb Res; 1999 Nov; 96(3):191-6. PubMed ID: 10588461
[TBL] [Abstract][Full Text] [Related]
46. The composition and daily variation of microparticles in whole blood in stable coronary artery disease.
Christersson C; Lindahl B; Siegbahn A
Scand J Clin Lab Invest; 2016; 76(1):25-32. PubMed ID: 26405844
[TBL] [Abstract][Full Text] [Related]
47. Glycemia, triglycerides and disease severity are best associated with higher platelet activity in patients with stable coronary artery disease.
Osmancik PP; Bednar F; Móciková H
J Thromb Thrombolysis; 2007 Oct; 24(2):105-7. PubMed ID: 17308964
[TBL] [Abstract][Full Text] [Related]
48. Elevated levels of 8-iso-prostaglandin F2alpha in acute coronary syndromes are associated with systemic and local platelet activation.
Szułdrzyński K; Zalewski J; Machnik A; Zmudka K
Pol Arch Med Wewn; 2010; 120(1-2):19-24. PubMed ID: 20150840
[TBL] [Abstract][Full Text] [Related]
49. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction.
Michelson AD; Barnard MR; Krueger LA; Valeri CR; Furman MI
Circulation; 2001 Sep; 104(13):1533-7. PubMed ID: 11571248
[TBL] [Abstract][Full Text] [Related]
50. [Effect of Puerarin on platelet activating factors CD63 and CD62P, plasminogen activator inhibitor and C-reactive protein in patients with unstable angia pectoris].
Luo ZR; Zheng B
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Jan; 21(1):31-3. PubMed ID: 12577374
[TBL] [Abstract][Full Text] [Related]
51. Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets.
Garlichs CD; Eskafi S; Raaz D; Schmidt A; Ludwig J; Herrmann M; Klinghammer L; Daniel WG; Schmeisser A
Heart; 2001 Dec; 86(6):649-55. PubMed ID: 11711459
[TBL] [Abstract][Full Text] [Related]
52. Platelet-derived TLT-1 is a prognostic indicator in ALI/ARDS and prevents tissue damage in the lungs in a mouse model.
Morales-Ortíz J; Deal V; Reyes F; Maldonado-Martínez G; Ledesma N; Staback F; Croft C; Pacheco A; Ortiz-Zuazaga H; Yost CC; Rowley JW; Madera B; John AS; Chen J; Lopez J; Rondina MT; Hunter R; Gibson A; Washington AV
Blood; 2018 Dec; 132(23):2495-2505. PubMed ID: 30282800
[TBL] [Abstract][Full Text] [Related]
53. Platelet bound oxLDL shows an inverse correlation with plasma anaphylatoxin C5a in patients with coronary artery disease.
Nording H; Giesser A; Patzelt J; Sauter R; Emschermann F; Stellos K; Gawaz M; Langer HF
Platelets; 2016 Sep; 27(6):593-597. PubMed ID: 27025272
[TBL] [Abstract][Full Text] [Related]
54. High plasma levels of adipocytokines are associated with platelet activation in patients with coronary artery disease.
Bigalke B; Stellos K; Geisler T; Seizer P; Mozes V; Gawaz M
Platelets; 2010; 21(1):11-9. PubMed ID: 19954410
[TBL] [Abstract][Full Text] [Related]
55. Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
Christersson C; Thulin Å; Siegbahn A
Thromb Haemost; 2017 Jul; 117(8):1571-1581. PubMed ID: 28424820
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effects of Terminalia arjuna on platelet activation in vitro in healthy subjects and patients with coronary artery disease.
Malik N; Dhawan V; Bahl A; Kaul D
Platelets; 2009 May; 20(3):183-90. PubMed ID: 19437336
[TBL] [Abstract][Full Text] [Related]
57. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
58. Soluble P-selectin levels in diabetes mellitus patients with coronary artery disease.
Aref S; Sakrana M; Hafez AA; Hamdy M
Hematology; 2005 Jun; 10(3):183-7. PubMed ID: 16019467
[TBL] [Abstract][Full Text] [Related]
59. Increased prolactin in acute coronary syndromes as putative Co-activator of ADP-stimulated P-selectin expression.
Raaz D; Wallaschofski H; Stumpf C; Yilmaz A; Cicha I; Klinghammer L; Daniel WG; Lohmann T; Garlichs CD
Horm Metab Res; 2006 Nov; 38(11):767-72. PubMed ID: 17111306
[TBL] [Abstract][Full Text] [Related]
60. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
